[Expression of DPP4 gene in papillary thyroid carcinoma]
- PMID: 17091451
[Expression of DPP4 gene in papillary thyroid carcinoma]
Abstract
Introduction: DPP4 gene (dipeptidyl peptidase IV) is expressed in epithelial cells of many organs and cells of immune system. There is no expression of DPP4 in normal healthy thyroid, while it is highly expressed in papillary thyroid carcinoma (PTC), as shown by gene expression profiling. In this study we validated expression of DPP4 in papillary thyroid cancer and normal thyroid tissue and evaluated its usefulness for diagnostic purposes.
Material and methods: The analysis was carried out on total RNA extracted from 102 PTCs and 77 normal thyroid fragments with use of Q-PCR reaction. Beta-glucuronidase was the reference gene.
Results: We confirmed the distinct increase of DPP4 expression in papillary thyroid carcinoma. However, the ROC (relative operating characteristic) analysis revealed that the diagnostic efficiency of DPP4 estimation is limited.
Conclusions: DPP4 is increased in papillary thyroid cancer, however, its diagnostic usefulness as a single PTC marker is doubtful.
Similar articles
-
Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.J Clin Endocrinol Metab. 2017 Aug 1;102(8):2930-2940. doi: 10.1210/jc.2017-00346. J Clin Endocrinol Metab. 2017. PMID: 28575350
-
[Expression of selected genes involved in transport of ions in papillary thyroid carcinoma].Endokrynol Pol. 2006;57 Suppl A:26-31. Endokrynol Pol. 2006. PMID: 17091453 Polish.
-
[Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer].Endokrynol Pol. 2006;57 Suppl A:18-25. Endokrynol Pol. 2006. PMID: 17091452 Polish.
-
Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.Exp Mol Pathol. 2015 Dec;99(3):393-8. doi: 10.1016/j.yexmp.2015.08.013. Epub 2015 Aug 29. Exp Mol Pathol. 2015. PMID: 26321247 Review.
-
MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.Int J Mol Sci. 2017 Mar 15;18(3):636. doi: 10.3390/ijms18030636. Int J Mol Sci. 2017. PMID: 28294980 Free PMC article. Review.
Cited by
-
Identification of genes differentially expressed in benign versus malignant thyroid tumors.Clin Cancer Res. 2008 Jun 1;14(11):3327-37. doi: 10.1158/1078-0432.CCR-07-4495. Clin Cancer Res. 2008. PMID: 18519760 Free PMC article.
-
A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.Bioengineered. 2021 Dec;12(1):2341-2351. doi: 10.1080/21655979.2021.1935400. Bioengineered. 2021. PMID: 34077308 Free PMC article.
-
DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.J Endocrinol Invest. 2021 Aug;44(8):1609-1623. doi: 10.1007/s40618-020-01455-7. Epub 2021 Jan 2. J Endocrinol Invest. 2021. PMID: 33387351
-
A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.Endocr Relat Cancer. 2007 Sep;14(3):809-26. doi: 10.1677/ERC-06-0048. Endocr Relat Cancer. 2007. PMID: 17914110 Free PMC article.
-
miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4.Onco Targets Ther. 2019 May 28;12:4225-4233. doi: 10.2147/OTT.S201532. eCollection 2019. Onco Targets Ther. 2019. PMID: 31213841 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous